Japan Proton Therapy holds more than two third of Market Share among Asian Countries

Renub Research latest study “Japan Proton Therapy Market, Forecast, Reimbursement Policies & Patients Treated at Centers” provides detailed overview of Japan Proton Therapy Market & Forecast along with patients database and medical coverage. Japan proton therapy market size is largest among Asian countries and it holds more than two third of market share in Asia Proton Therapy Market.

Massive Cancer Patients of Japan Stand in Queue for Proton Therapy

The number of proton therapy centers in Japan is comparatively more than any other Asian countries and it is growing at rapid pace. Still, industry professionals recognize the huge gap between demand of proton therapy and services delivered in Japan. Rising number of cancer diagnosed patients with very critical tumor has only option for proton therapy. Chemotherapy and surgery are no more right choice for them due to patient awareness of proton therapy and its benefits.

Japan at Forefront of Tomorrow High-Tech Proton Therapy

Japan National Cancer Center Hospital only uses cyclotron accelerator to provide more effective, faster and more precise cancer treatment, which mitigate stress of the patient. The facility specializes in the comprehensive treatment of cancer and it has ability to mix numerous other therapies, in the context of the actual disease for better outcome. The optimum use of clinical development process explores various forms of irradiation technology on the continuous basis e.g. imaging technology and dose simulation technology. This center is predicted that within the time-frame of 2-3 years, they will be able to perform Intensity Modulated Proton Therapy (IMPT) in therapeutic applications. In the current scenario, it is still in the research phase globally. Moreover, robotics has been inducting into proton therapy systems for improved outcome in the management of patient transport, patient treatment positioning, treatment appliances, and imaging systems.

For More Information: http://www.renub.com/japan-proton-therapy-holds-more-than-two-third-of-market-share-among-asian-countries-26-nd.php

Contact Us

Rajat Gupta
Business Development Manager
Email: info@renub.com
Phone: +1-678-302-0700 (USA), +91-120-421-9822 (India)
Web: http://www.renub.com

Renub Research is a leading Market Research and Information Analysis Company with centers at Noida India and Roswell USA. We have long-term experience especially in international Business-to-Business Researches, Surveys, Business and Consulting. Throughout the years we have acquired expertise in most market sectors, including Information Technology (IT), Telecoms, Life Sciences, Medical & Pharmaceuticals, Financial Services (Banking, Insurance, Reinsurance, M&A, etc.), Energy, Chemicals, Automotive, Retail, FMCG, Consumer Goods, Logistics, Governmental, Social, and Others.

Our core team is comprised of an experienced people holding graduate, post graduate and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science and many more. Our research help make the business decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We support many blue chip companies by providing them findings and perspectives across a wide range of markets. Our research reports offer a blend of information insight, analysis and forecasting that is essential in today’s ultra-competitive markets.

225 Kristie Ln, Roswell, GA 30076, United States

This release was published on openPR.